WHO ICTRP trial
Phase 2 study for SAR443820 in participants with amyotrophic lateral sclerosis…
EUCTR2021-004156-42-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2021-004156-42-NL |
|---|---|
| Public title | Phase 2 study for SAR443820 in participants with amyotrophic lateral sclerosis (ALS) |
| Scientific title | A Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of SAR443820 in adult participants with amyotrophic lateral sclerosis, followed by an open-label extension |
| Primary sponsor | Sanofi-aventis recherche & développement |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Japan;United Kingdom;Spain;Canada;Netherlands;Sweden;Belgium;China;Poland;Italy;France;Germany |
| Conditions | Amyotrophic lateral sclerosis MedDRA version: 21.1 Level: PT Classification code 10002026 Term: Amyotrophic lateral sclerosis System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases… |
| Interventions | Product Code: SAR443820 Pharmaceutical Form: Film-coated tablet CAS Number: 2252271-93-3 Current Sponsor code: SAR443820 Other descriptive name: RA15804589, C19061501-F, DNL788, DN2489, DN0002489 Concentration unit: mg milligram(s)… |
| Registration date | Dec 21, 2021 |
| Target size | 261 |
| Secondary IDs | ACT16970;2021-004156-42-SE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: